Trially Inc. operates an AI-native clinical trial recruitment platform that utilizes HIPAA-compliant LLM agents to match, engage, and enroll qualified participants.
Subscribe to see Trially Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Trially Inc. is a biotech and healthcare company headquartered in Kansas City, United States. Its most recent funding round, Seed, raised $4.8M in August 2025. Xcout tracks 8 named people at Trially Inc., including Kyle McAllister (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
2 more named people on record for Trially Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $4.8M | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Trially Inc.'s closest competitors — see the full list of competitors and alternatives →
Hill Research is a healthcare artificial intelligence and clinical research company based in Boston, Massachusetts, with additional presence in Princeton, New Jersey. The company leverages generative AI and multi-agent automation to accelerate clinical trials, biostatistics, and FDA submissions.
Ryght AI is an artificial intelligence company headquartered in Southern California that provides an AI-powered platform to rapidly analyze clinical trial protocols and connect researchers with sites worldwide.
Cori Clinical is a research services company headquartered in London, United Kingdom, providing artificial intelligence applications for clinical trials.
MDVerse Inc. provides a software, analytics, and generative AI platform designed to support the advanced therapy medicinal products (ATMP) ecosystem. The company integrates drug creators, pharmaceutical companies, contract manufacturers, and clinical sites to streamline the supply chain, manufacturing, and delivery of precision cell and gene therapies.
Triomics, Inc. is a U.S. healthcare technology company that uses artificial intelligence and natural-language processing to structure oncology data from clinical records and genomic reports. Its platform serves cancer centers, oncologists, and life-sciences organizations by supporting precision-oncology workflows such as clinical-trial matching and patient identification.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Trially Inc.? Suggest a correction · Work at Trially Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.